Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
martin.little@oncology.ox.ac.uk

Martin Little

Clinical Research Training Fellow

Recent publications

The immunomodulatory role of human cytomegalovirus in cancer in the era of checkpoint immunotherapy.

Bremke J. et al, (2025), Philos Trans R Soc Lond B Biol Sci, 380

Defining the genetic determinants of CD8+ T cell receptor repertoire in the context of immune checkpoint blockade.

Ng ES. et al, (2025), Sci Adv, 11

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.

Milotay G. et al, (2025), Nat Med, 31, 2350 - 2364

Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiative.

Appanna N. et al, (2025), Int J Cancer, 156, 2087 - 2093

UK cancer vaccine advance - Recognising and realising opportunities.

Craddock C. et al, (2025), Camb Prism Precis Med, 3